Tech Company Financing Transactions
X-Biotix Therapeutics Funding Round
X-Biotix Therapeutics closed a $7 million Series A funding round on 4/25/2018. Investors included private investors.
Transaction Overview
Company Name
Announced On
4/25/2018
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds of the financing will enable X-Biotix to advance its pipeline of novel antibiotic candidates targeting a wide range of biological targets in essential pathways of Gram-negative bacterial cells.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
465 Waverley Oaks Rd. 414
Waltham, MA 02452
USA
Waltham, MA 02452
USA
Phone
Website
Email Address
Overview
X-Biotix is a discovery, early preclinical-stage company that was spun out of X-Chem and incorporated in 2016, with a focus on delivering the next generation of antibiotics to combat multi-drug resistant Gram-negative pathogens.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ramani Varanasi
Chief Financial Officer
Gregg Beloff
Chief Scientific Officer
Dominic Ryan
Browse more venture capital transactions:
Prev: 4/25/2018: Culture Trip venture capital transaction
Next: 4/25/2018: Etleap venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs